Primary paranasal sinus lymphoma: natural history and improved outcome with central nervous system chemoprophylaxis

References

• Abbondanzo S L, Wenig B M. Non-Hodgkin's lymphoma of the sinonasal tract. A clinicopathologic and immunophenotypic study of 120 cases. Cancer 1995; 75: 1281–1291
   PubMed Web of Science ®Google Scholar
• Logsdon M D, Ha C S, Kavadi V S, Cabanillas F, Hess M A, Cox J D. Lymphoma of the nasal cavity and paranasal sinuses: improved outcome and altered prognostic factors with combined modality therapy. Cancer 1997; 80: 477–488
   PubMed Web of Science ®Google Scholar
• Cooper D L, Ginsberg S S. Brief chemotherapy, involved field radiation therapy, and central nervous system prophylaxis for paranasal sinus lymphoma. Cancer 1992; 69: 2888–2893
   PubMed Web of Science ®Google Scholar
• Vidal R W, Devaney K, Ferlito A, Rinaldo A, Carbone A. Sinonasal malignant lymphomas: a distinct clinicopathological category. Ann Otol Rhinol Laryngol 1999; 108: 411–419
   PubMed Web of Science ®Google Scholar
• Jacobs C, Hoppe R T. Non-Hodgkin's lymphomas of head and neck extranodal sites. Int J Radiat Oncol Biol Phys 1985; 11: 357–364
   PubMed Web of Science ®Google Scholar
• Cuadra-Garcia I, Proulx G M, Wu C L, Wang C C, Pilch B Z, Harris N L, et al. Sinonasal lymphoma: a clinicopathologic analysis of 58 cases from the Massachusetts General Hospital. Am J Surg Pathol 1999; 23: 1356–1369
   PubMed Web of Science ®Google Scholar
• Nakamura K, Uehara S, Omagari J, Kunitake N, Jingu K, Masuda K. Primary non-Hodgkin's lymphoma of the maxillary sinus. Am J Clin Oncol 1997; 20: 272–275
   PubMed Web of Science ®Google Scholar
• Hausdorff J, Davis E, Long G, Hoppe R, van der Pas M, Lassman C, et al. Non-Hodgkin's lymphoma of the paranasal sinuses: clinical and pathological features, and response to combined-modality therapy. Cancer J Sci Am 1997; 3: 303–311
   PubMed Web of Science ®Google Scholar
• Yuen A, Jacobs C. Lymphomas of the head and neck. Semin Oncol 1999; 26: 338–345
   PubMed Web of Science ®Google Scholar
• Quraishi MSB E M, Clark D, Jones N S, Bradley P J. Non-Hodgkin's lymphoma of the sinonasal tract. Laryngoscope 2000; 110: 1489–1492
   PubMed Web of Science ®Google Scholar
• Shohat IB M, Dori S, Horowitz Z, Wolf M, Talmi Y P. Primary non-Hodgkin's lymphoma of the sinonasal tract. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2004; 97: 328–331
   PubMed Web of Science ®Google Scholar
• Robbins K T, Fuller L M, Vlasak M, Osborne B, Jing B S, Velasquez W S, et al. Primary lymphomas of the nasal cavity and paranasal sinuses. Cancer 1985; 56: 814–819
   PubMed Web of Science ®Google Scholar
• Liang R, Todd D, Chan T K, Chiu E, Lie A, Kwong Y L, et al. Treatment outcome and prognostic factors for primary nasal lymphoma. J Clin Oncol 1995; 13: 666–670
   PubMed Web of Science ®Google Scholar
• Frierson H F, Jr, Mills S E, Innes D J, Jr. Non-Hodgkin's lymphomas of the sinonasal region: histologic subtypes and their clinicopathologic features. Am J Clin Pathol 1984; 81: 721–727
   PubMed Web of Science ®Google Scholar
• Fisher R I, Gaynor E R, Dahlberg S, Oken M M, Grogan T M, Mize E M, et al. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma. N Engl J Med 1993; 328: 1002–1006
   PubMed Web of Science ®Google Scholar
• Kaplan E, Meier P. Nonparametric estimation from incomplete observation. J Am Stat Assoc 1958; 53: 457–445
   Web of Science ®Google Scholar
• Cheung M C, Chan J K, Lau W H, Ngan R K, Foo W W. Early stage nasal NK/T-cell lymphoma: clinical outcome, prognostic factors, and the effect of treatment modality. Int J Radiat Oncol Biol Phys 2002; 54: 182–190
   PubMed Web of Science ®Google Scholar
• Li Y X, Coucke P A, Li J Y, Gu D Z, Liu X F, Zhou L Q, et al. Primary non-Hodgkin's lymphoma of the nasal cavity: prognostic significance of paranasal extension and the role of radiotherapy and chemotherapy. Cancer 1998; 83: 449–456
   PubMed Web of Science ®Google Scholar
• Maeda H, Aozasa K, Tsujimura T, Sasaki R, Yoshida J, Matsunaga T. Malignant lymphomas and related conditions involving nasal cavity and paranasal sinuses: a clinicopathologic study of 42 cases with emphasis on prognostic factors. Eur J Surg Oncol 1988; 14: 9–15
   PubMed Web of Science ®Google Scholar
• Li CCT H F, Tang J L, Yao M, Chen Y C, Su I J, Hsu S M, Hong R L. Treatment outcome and pattern of failure in 77 patients with sinonasal natural killer/T-cell or T-cell lymphoma. Cancer 2004; 100: 366–375
   PubMed Web of Science ®Google Scholar
• Hatta CO H, Okita J, Kubota A, Sakagami M. Non-Hodgkin's malignant lymphoma of the sinonasal tract–treatment outcome for 53 patients according to REAL. Auris Nasus Larynx 2001; 28: 55–60
   PubMed Web of Science ®Google Scholar
• Woo JSK J M, Lee S H, Chae S W, Hwang S J, Lee H M. Clinical analysis of extranodal non-Hodgkin's lymphoma in the sinonasal tract. Eur Arch Otorhinolaryngol 2004; 261: 197–201
   PubMed Web of Science ®Google Scholar
• Kondo M, Mikata A, Inuyama Y, Uematsu M, Shigematsu N, Nishiguchi I, et al. Treatment of non-Hodgkin lymphomas in the nasal cavities and paranasal sinuses. A failure analysis. Acta Radiol Oncol 1986; 25: 91–97
   PubMed Web of Science ®Google Scholar
• Tran L M, Mark R, Fu Y S, Calcaterra T, Juillard G. Primary non-Hodgkin's lymphomas of the paranasal sinuses and nasal cavity. A report of 18 cases with stage IE disease. Am J Clin Oncol 1992; 15: 222–225
   PubMed Web of Science ®Google Scholar